hrp0095p2-310 | Late Breaking | ESPE2022

GH Treatment in A Girl with Acrodysostosis Type 2 Due to Novo Mutation in PDE4D gene

Nikitas Skarakis Spyridon , Karachaliou Fotini-Heleni , Simatou Aristofania , Tsintzou Eleni , Papadopoulou Anna

Acrodysostosis (ACRDYS) (MIM 101800) is a rare autosomal dominant condition affecting skeletal growth and resulting in primary skeletal dysplasia. Two types of ACRDYS have been described and characterized by distinct references on OMIM database. ACRDYS is similar and often confused with PHP1A, but caused by mutations downstream of the genes involved in PHP1A. Most of the patients have de novo variants. Both types of ACRDYS present with similar skeletal abnormalities (dispropor...

hrp0092fc10.5 | Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology | ESPE2019

Transcriptome Analysis of Novel Sertoli Cell Models to Highlight Potential Genes Involved in DSD Mechanism of Disease

Gutiérrez Daniel Rodríguez , Sproll Patrick , Biason-Lauber Anna

Background: Determination of the gonads in men is closely dependent on Sertoli cells differentiation and maturation. Many cases of differences of sex development (DSD) are caused by variations in these processes. The study of the mechanisms underlying these complex conditions is crucial for optimal clinical management and Sertoli cells would be an ideal model for this purpose. Our human Sertoli-like cell model (SLCs) may shed some light on the identification o...

hrp0092rfc10.5 | Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology | ESPE2019

VVariants in NWD1 Gene Leading to Different Degrees of Gonadal Dysgenesis

Aeppli Tim , Gaisl Odile , Sproll Patrick , Lang-Muritano Mariarosaria , Nef Serge , Konrad Daniel , Biason-Lauber Anna

Introduction: Mammalian sex development is directly dependent on gonadal determination. Whole exome sequencing in patients with differences of sex development (DSD) allows the discovery of new factors involved in human sex development. One of these factors is NWD1 (NACHT and WD repeat domain containing 1) a cytosolic protein that seems to play a role in modulating androgen receptor signaling. We identified variants in the NWD1 gene in six und...

hrp0092rfc12.2 | Growth and Syndromes (to include Turner syndrome) | ESPE2019

Treatment with Growth Hormone Increases Klotho Concentration in Patients with Turner Syndrome

Wikiera Beata , Seifert Monika , Nocon-Bohusz Julita , Noczynska Anna , Daroszewski Jacek

Background: Short stature, increased adiposity and insulin resistance are conditions frequently observed in patients with Turner syndrome (TS). Many hormones are involved in the pathogenesis of the condition but therapeutic options we can offer to the patients are still scant. Each newly discovered peptide give us hope. Klotho play a very important role in the regulation of the human body metabolism and was not investigated in patients with TS so far.<p cl...

hrp0092p1-21 | Bone, Growth Plate and Mineral Metabolism | ESPE2019

Dual X-ray Absorptiometry in Children With Hypophosphatasia Treated with Asfotase Alfa: A Pooled Post Hoc Analysis

Simmons Jill H. , Rush Eric T. , Petryk Anna , Zhou Shanggen , Martos-Moreno Gabriel Á.

Hypophosphatasia (HPP) is a rare, inherited, systemic disease characterized by deficient tissue-nonspecific alkaline phosphatase activity. Common manifestations in children include impaired skeletal mineralization, short stature, and reduced physical function. Asfotase alfa is an enzyme replacement therapy approved for treatment of patients of any age with pediatric-onset HPP. The utility of dual X-ray absorptiometry (DXA) as a diagnostic tool or measure of treatment effective...

hrp0092p1-22 | Bone, Growth Plate and Mineral Metabolism | ESPE2019

Differences in Bone Strength and Cortical Bone Parameters in Young Swedish Women with Type 1 Diabetes

Kristiansen Eva , Novak Daniel , Forsander Gun , Svedlund Anna , Magnusson Per , Swolin-Eide Diana

Background: The incidence of Type 1 diabetes (T1D) is rising globally and fractures are common.Objective: To investigate bone health in young females with a T1D duration of at least 10 years in relation to healthy, matched controls.Subjects: Twenty-three Swedish females, aged 19.2– 27.9 years, with a T1D duration of ≥10 years, were recruited from the Swedish National Dia...

hrp0092p1-54 | Fat, Metabolism and Obesity | ESPE2019

Augmented Fibroblast Growth Factor 21 Serum Levels in Metabolic Disorders and Association With Endothelial Function in Childhood

Domouzoglou Eleni , Vlahos Antonios , Challa Anna , Papafaklis Michail , Tsatsoulis Agathocles , Michalis Lampros , Chaliasos Nikolaos , Naka Katerina

Introduction: Obesity and the metabolic syndrome (MetS) are linked to increased risk for endothelial dysfunction which is considered as the first step in the progression of cardiovascular disease. Fibroblast growth factor 21 (FGF21) is a protein with known effects on various metabolic pathways. In adults, the circulating blood levels of FGF21 have been associated with parameters of lipid/carbohydrate metabolism, and FGF21 is known to be increased in obesity. T...

hrp0092p1-55 | Fat, Metabolism and Obesity | ESPE2019

A Novel Recurrent Heterozygous Plin1 Mutation in Three Russian Patients with Partial Lipodystrophy, Dyslipidemia and Insulin Resistance

Tikhonovich Yulia , Sorkina Ekaterina , Kolodkina Anna , Vasilyev Evgeniy , Petrov Vasiliy , Pogoda Tatyana , Vasiukova Olga , Tiulpakov Anatoly

Introduction: The PLIN1 gene encodes perilipin - a lipid droplet coat protein expressed in adipocytes where it inhibits basal and facilitates stimulated lipolysis. Mutations in PLIN1 have been described in several families with partial lipodystrophy, dyslipidemia and insulin resistance (partial lipodystrophy type 4, Familial, FPLD4). Herein we describe a novel heterozygous c.1210-1delG splicing variant in PLIN1 gene in three unrelate...

hrp0092p1-93 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019

Persisting Embryonal Infundibular Recess in a Patient with Morning Glory Syndrome and Multiple Pituitary Deficiencies

FESTA ADALGISA , GRANDONE ANNA , LUONGO CATERINA , CIRILLO GRAZIA , del GIUDICE EMANUELE MIRAGLIA

A 5-year old boy was referred to our clinic for short stature reported since first years of life. At birth weight and length were normal, psychomotor development was regular, target height was 165.9 cm. At 7 months of life he was subjected to correction of cleft lip-palate. Since 3 years of life he suffered from headache, for which a fundoscopy was performed and revealed a Morning Glory Disc Anomaly (MGDA) of the right eye. At our first visit height was 98.2 cm (-2.5DS), body ...

hrp0092p1-169 | Bone, Growth Plate and Mineral Metabolism (1) | ESPE2019

Hypercalcemia as a Post Stem Cell Transplantation Complication in Children with Osteopetrosis - A Single Centre Experience

Paul Praveen George , N.A Fouzia , Korula Sophy , Mathai Sarah , George Biju , Simon Anna

Introduction: Osteopetrosis (OP) is a rare genetic disorder that is characterized by abnormal osteoclast function resulting in dense bones and marrow failure. The only definitive cure for OP is stem cell transplantation (SCT). Hypercalcemia is a well described complication in children with OP undergoing SCT. This study describes the calcium profile and treatment modalities used to maintain normocalcemia in children with OP undergoing SCT.<p class="abstext"...